Home > Insider Trading > Filing (0000200406-10-000100)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
200406	Johnson & Johnson	JNJ	Pharmaceutical Preparations (2834)	221024240

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1142630	James Cullen	Johnson &Amp; Johnson One Johnson &Amp; Johnson Plaza New Brunswick NJ 08933		Yes	No	No	No

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership
Common	Acquisiton	2010-11-12	5,400	$51.57	16,092	No	4	M	Direct
Common	Disposition	2010-11-12	5,400	$63.66	10,692	No	4	S	Direct
Common	Disposition	2010-11-15	5,763	$64.18	4,929	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership
No	4	M	Direct
No	4	S	Direct
No	4	S	Direct

Reported Derivative Transactions

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common	Non-Employee Director Stock Options (Right to Buy)	Disposition	2010-11-12	5,400	$0.00	5,400	$51.57

Remaning Holdings	Exercise Date	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
0	2002-01-02	2010-12-31	No	4	M	Direct

Reported Derivative Holdings

Sec. Name	Sec. Type	Price	Date	Expiration Date	Amount	Remaning Holdings	Nature of Ownership
Common	Phantom Stock Units	$0.00			0	30,443	Direct

Expiration Date	Amount	Remaning Holdings	Nature of Ownership
	0	30,443	Direct

Footnotes

Adjusted to reflect two-for-one stock split in 2001.
Includes total of 1,015 shares held under Issuer's Dividend Reinvestment Plan (269 previously unreported) which were sold on 11/15/2010 in accordance with this report.
This transaction was executed in multiple trades at prices ranging from $64.14 to $64.23. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
The Phantom Stock Units held under the Issuer's Non-Employee Director Deferred Fee Planare to be settled in cash upon the Reporting Person's Retirement (with each Phantom Stock Unit representing the fair market value of one share of Common Stock on the settlement date). Alternatively, the cash value represented by the Phantom Stock Units may be transferred by the Reporting Person into an alternative investment account under the Plan at any time.
1 for 1
Awarded under the Stock Option Plan for Non-Employee Directors and exercisable in full one year from date of grant.